Notice for tepotinib (as hydrochloride monohydrate) (Merck Healthcare Pty Ltd)
Active ingredients
tepotinib (as hydrochloride monohydrate)
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Therapeutic area
Oncology